Trauma Department, Hanover Medical School, Carl-Neuberg-Strasse 1, 30625 Hanover, Germany.
Injury. 2009 May;40(5):528-34. doi: 10.1016/j.injury.2008.08.007. Epub 2008 Dec 2.
Posttraumatic systemic inflammatory response syndrome (SIRS), sepsis and their subsequent complication, the multiple-organ dysfunction syndrome (MODS), remain major complications following polytrauma. This prospective clinical study aimed at evaluating the association between these and plasma interleukin-18 (IL-18) and neopterin levels.
Inclusion in the series required an Injury Severity Score (ISS) >16, age 16-65 years, admission within 6 h of the accident and survival >48 h; 55 patients were enrolled. Over 14 days, plasma neopterin and IL-18 levels and the clinical course regarding MODS, SIRS and sepsis were recorded daily using the Marshall Score for MODS and the ACCP/SCCM criteria for SIRS and sepsis.
Neopterin and IL-18 plasma levels were increased in +MODS cases as compared with -MODS cases over almost the entire observation period. IL-18 concentrations over days 3-6 were significantly increased among participants with sepsis. These increases were all apparent 2-3 days before the clinical diagnosis of sepsis or MODS was made. In contrast, no significant differences in neopterin and IL-18 plasma levels were observed between participants with and without SIRS.
Determinations of neopterin and IL-18 concentrations might represent early markers for posttraumatic complications such as MODS and sepsis. They might help to differentiate between SIRS and sepsis and thereby guide the timing of the surgery for polytrauma. Neopterin and IL-18 levels should be used together with the clinical status and other inflammatory markers (IL-6, IL-8, etc.) for prediction of posttraumatic complications.
创伤后全身炎症反应综合征(SIRS)、败血症及其随后的并发症多器官功能障碍综合征(MODS)仍然是多发伤后的主要并发症。本前瞻性临床研究旨在评估这些并发症与血浆白细胞介素 18(IL-18)和新蝶呤水平之间的关系。
该系列纳入标准为损伤严重程度评分(ISS)>16、年龄 16-65 岁、伤后 6 小时内入院且存活>48 小时;共纳入 55 例患者。在 14 天内,使用 Marshall MODS 评分和 ACCP/SCCM 标准对 SIRS 和败血症的 MODS、SIRS 和败血症的临床过程进行记录,并每天记录血浆新蝶呤和 IL-18 水平。
与无 MODS 病例相比,+MODS 病例的血浆新蝶呤和 IL-18 水平在几乎整个观察期内均升高。在发生败血症的患者中,第 3-6 天的 IL-18 浓度显著升高。这些增加在败血症或 MODS 的临床诊断做出前 2-3 天即可明显看出。相比之下,在有无 SIRS 的患者之间,血浆新蝶呤和 IL-18 水平无显著差异。
新蝶呤和 IL-18 浓度的测定可能是创伤后并发症(如 MODS 和败血症)的早期标志物。它们可能有助于区分 SIRS 和败血症,并指导多发伤手术时机。新蝶呤和 IL-18 水平应与临床状态和其他炎症标志物(IL-6、IL-8 等)一起用于预测创伤后并发症。